In men and women with CLL, high UGT2B17 mRNA expression in PBMCs was associated with the adverse prognostic marker unmutated IGHV, and with high CD38 expression in female cases (Table 4). The gene discussed is UGT2B17; the disease is B-cell chronic lymphocytic leukemia.